China $37 Billion Jiangsu Hengrui Pharmaceuticals Files for Hong Kong Secondary IPO, Originally Founded as China State-Owned Lianyungang Pharmaceutical Factory in 1970, IPO on Shanghai Stock Exchange in 2000
14th January 2025 | Hong Kong
China Jiangsu Hengrui Pharmaceuticals ($37 billion market value) has filed for a Hong Kong secondary IPO. Jiangsu Hengrui Pharmaceuticals was originally founded as a China state-owned enterprise Lianyungang Pharmaceutical Factory in 1970. Jiangsu Hengrui Pharmaceuticals IPO on Shanghai Stock Exchange in 2000. Hengrui Pharma is a leading global pharmaceutical company committed to promoting a healthier life for humankind through advancements in science. Hengrui Pharma has been on the Pharma Exec’s annual listing of the top 50 global pharmaceutical companies for the fifth consecutive year. With an established portfolio of high-quality medicines and an extensive pipeline of first-in-class and best-in-class assets across multiple therapeutic areas including oncology, diabetes, cardiovascular, autoimmune and respiratory, Hengrui Pharma is focused on innovation to benefit patients globally. We have 14 R&D centers of excellence in Lianyungang, Shanghai, the U.S. and Europe, 8 major manufacturing sites, and leading technology platforms supported by a dedicated R&D team of more than 5,000 professionals that enable us to accelerate drug development. Hengrui Pharma maximizes the impact of its innovation by collaborating with global partners to address unmet medical needs and improve the lives of patients in China and around the world.
“ China $37 Billion Jiangsu Hengrui Pharmaceuticals Files for Hong Kong Secondary IPO, Originally Founded as China State-Owned Lianyungang Pharmaceutical Factory in 1970, IPO on Shanghai Stock Exchange in 2000 “
China $37 Billion Jiangsu Hengrui Pharmaceuticals Files for Hong Kong Secondary IPO, Originally Founded as China State-Owned Lianyungang Pharmaceutical Factory in 1970, IPO on Shanghai Stock Exchange in 2000
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2025 Investment Day
- March - Hong Kong
- March - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit